The only antiviral drug currently used to treat SARS-CoV-2, the coronavirus that causes COVID-19, is remdesivir, but administering it is invasive and challenging. Scientists at The University of Texas at Austin are hoping ...
Jul 29, 2020
0
54
An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola ...
Apr 8, 2015
0
3926
The pathogens mosquitoes spread by sucking our blood cause over half a million deaths each year and hundreds of millions of cases of severe illness.
Mar 31, 2020
0
15
A new study at Texas Biomedical Research Institute is shedding light on the role of specific proteins that trigger a mechanism allowing Ebola virus to enter cells to establish replication. The work, published in a supplement ...
Aug 8, 2018
0
272
The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as ...
Aug 27, 2022
0
89
(Medical Xpress)—A genetics research team led by Pardis Sabeti of Harvard University has published a paper in the journal Science, suggesting that some infectious diseases that are thought to be relatively new, may in fact ...
Nine days before Ebola was declared an epidemic, a group of researchers and computer scientists in Boston spotted the hemorrhagic fever beginning to spread in Guinea.
Oct 26, 2014
0
0
An international team including scientists from Albert Einstein College of Medicine of Yeshiva University and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has identified the molecular "lock" ...
May 26, 2015
0
216
On August 26, 1976, a time bomb exploded in Yambuku, a remote village in Zaire, (now the Democratic Republic of the Congo). A threadlike virus known as Ebola had emerged, soon earning a grim distinction as one of the most ...
Dec 5, 2011
0
0
A team of researchers has identified a cellular protein that acts as a receptor for Ebola virus and Marburg virus. Furthermore, the team showed that an antibody, which binds to the receptor protein, is able to block infection ...
May 2, 2011
0
0
